Prevalence of EED and quality of life evaluated by Gastroesophageal Reflux Disease (GERD)-Q in Korean GERD patients - Preedom
Study identifier:NIS-GKR-DUM-2008/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Prevalence of EED and quality of life evaluated by Gastroesophageal Reflux Disease (GERD)-Q in Korean GERD patients
Medical condition
Gastroesophageal Reflux Disease
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
2000
Study type
Observational
Age
20 Years - 80 Years
Date
Study Start Date: 01 Sept 2008
Primary Completion Date: -
Study Completion Date: 01 Feb 2009
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
Contacts
Investigators
Principal Investigator
Joon-Woo Bahn
AstraZeneca Korea
